56
Participants
Start Date
October 14, 2019
Primary Completion Date
April 3, 2023
Study Completion Date
October 1, 2023
mirabegron 50 mg daily
Patients in both study groups will receive 50 mg of mirabegron daily in the form of tablets, which is used to treat OAB according to current treatment guidelines.
Extracorporeal magnetic innervation (active treatment)
Patients will twice a week receive extracorporeal electromagnetic stimulation in the duration of 20 minutes. Patients will be randomized into 2 study groups, namely one group will receive actual electromagnetic stimulation, and the other group will receive sham stimulation.
Extracorporeal magnetic innervation (sham treatment)
Patients will twice a week receive extracorporeal electromagnetic stimulation in the duration of 20 minutes. Patients will be randomized into 2 study groups, namely one group will receive actual electromagnetic stimulation, and the other group will receive placebo stimulation.
University Medical Centre Maribor, Maribor
Serdinsek Tamara
OTHER